Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 81.01B | 80.39B | 79.24B | 77.65B | 71.89B | 69.69B |
Gross Profit | 22.25B | 22.26B | 22.05B | 21.76B | 20.72B | 20.41B |
EBITDA | 3.89B | 4.08B | 4.53B | 4.85B | 4.87B | 3.78B |
Net Income | 954.30M | 958.60M | 1.30B | 1.51B | 1.62B | 850.20M |
Balance Sheet | ||||||
Total Assets | 26.47B | 29.31B | 28.79B | 28.75B | 30.77B | 29.39B |
Cash, Cash Equivalents and Short-Term Investments | 151.00M | 339.20M | 212.00M | 477.20M | 2.97B | 1.78B |
Total Debt | 14.31B | 14.18B | 14.24B | 15.01B | 15.30B | 16.07B |
Total Liabilities | 23.25B | 25.92B | 26.05B | 27.14B | 27.75B | 28.06B |
Stockholders Equity | 3.22B | 3.39B | 2.75B | 1.61B | 3.02B | 1.32B |
Cash Flow | ||||||
Free Cash Flow | 501.30M | 749.40M | 628.20M | 700.00M | 1.91B | 2.27B |
Operating Cash Flow | 2.47B | 2.68B | 2.66B | 2.85B | 3.51B | 3.90B |
Investing Cash Flow | -1.83B | -1.89B | -1.75B | -1.98B | -1.54B | -1.57B |
Financing Cash Flow | -786.20M | -684.10M | -1.18B | -3.37B | -789.50M | -1.04B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
70 Outperform | $46.08B | 18.94 | 24.06% | 1.88% | -2.11% | 25.03% | |
68 Neutral | $14.23B | 30.01 | 36.94% | ― | 16.83% | 52.71% | |
67 Neutral | $1.74B | 17.47 | 7.86% | 1.94% | 2.49% | 15.99% | |
66 Neutral | £7.72B | 8.30 | 7.55% | 3.55% | 2.08% | 24.83% | |
63 Neutral | $1.80B | 231.15 | 0.68% | ― | 8.47% | -85.17% | |
61 Neutral | $10.74B | 11.70 | 31.10% | 2.97% | 1.96% | -14.99% | |
52 Neutral | $1.19B | 21.62 | 3.58% | 1.03% | -7.96% | -64.67% |
On August 7, 2025, Albertsons Companies held its annual meeting of stockholders where several key proposals were voted on. Directors were elected for the upcoming year, Deloitte & Touche LLP was ratified as the independent accounting firm, and executive compensation was approved. However, stockholder proposals on food waste reporting, human rights policy, and reproductive health care risks were not approved, indicating a focus on traditional business operations over expanded social responsibility reporting.
The most recent analyst rating on (ACI) stock is a Buy with a $27.00 price target. To see the full list of analyst forecasts on Albertsons Companies stock, see the ACI Stock Forecast page.